Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Physiology & Behavior|July 1, 1999
Age-induced cognitive alterations in OF1 miceI Carrié, M Debray, J M Bourre, et al.
The British Journal of Nutrition|June 20, 2000
Diets containing long-chain n-3 polyunsaturated fatty acids affect behaviour differently during development than ageing in miceI Carrié, P Guesnet, J M Bourre, et al.
Journal of Psychopharmacology (Oxford, England)|September 6, 2011
Effects of positive modulators of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)-type glutamate receptors in a benzodiazepine-induced deficit of spatial discrimination in miceM Vandesquille, I Carrié, C Louis, et al.
Neuroscience Letters|May 21, 1999
Learning deficits in first generation OF1 mice deficient in (n-3) polyunsaturated fatty acids do not result from visual alterationI Carrié, M Clément, D De Javel, et al.
Journal of Lipid Research|March 8, 2000
Phospholipid supplementation reverses behavioral and biochemical alterations induced by n-3 polyunsaturated fatty acid deficiency in miceI Carrié, M Clément, D de Javel, et al.
Journal of Lipid Research|March 8, 2000
Specific phospholipid fatty acid composition of brain regions in mice. Effects of n-3 polyunsaturated fatty acid deficiency and phospholipid supplementationI Carrié, M Clément, D de Javel, et al.
Neuroscience Letters|May 12, 2000
Nutritional (n-3) polyunsaturated fatty acids influence the behavioral responses to positive events in miceH Francès, P Draï, M Smirnova, et al.
Current Pharmaceutical Design|January 1, 2010
PUFA for prevention and treatment of dementia?I Carrié, G Abellan Van Kan, Y Rolland, et al.
Nutritional Neuroscience|April 4, 2002
Docosahexaenoic acid-rich phospholipid supplementation: effect on behavior, learning ability, and retinal function in control and n-3 polyunsaturated fatty acid deficient old miceI Carrié, M Smirnova, M Clément, et al.
The Journal of Prevention of Alzheimer'S Disease|September 29, 2021
The Cost-Effectiveness of Three Prevention Strategies in Alzheimer's Disease: Results from the Multidomain Alzheimer Preventive Trial (MAPT)N Costa, M Mounié, A Pagès, et al.
Pageof 2